Role of epidermal growth factor inhibition in experimental pulmonary hypertension. (Q43256381)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

Role of epidermal growth factor inhibition in experimental pulmonary hypertension (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author

Soni Savai Pullamsetti

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Ardeschir Ghofrani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Norbert Weissmann

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Werner Seeger

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Friedrich Grimminger

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Ralph T Schermuly

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

9

Robert Voswinckel

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

6

Rio Dumitrascu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1

Bhola Kumar Dahal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

2

Teodora Cornitescu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

3

Aleksandra Tretyn

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

5

Djuro Kosanovic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

10

Gamal-Andre Banat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

language of work or name

English

0 references

publication date

22 October 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

10 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

158-167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19850946%20AND%20SRC:MED&resulttype=core&format=json

Treatment of pulmonary arterial hypertension

10 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Reversal of experimental pulmonary hypertension by PDGF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Long term imatinib treatment in pulmonary arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Imatinib for the treatment of pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

A role for platelet-derived growth factor beta-receptor in a newborn rat model of endothelin-mediated pulmonary vascular remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Alterations in Ca2+ cycling by lysoplasmenylcholine in adult rabbit ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Epidermal growth factor receptor blockade mediates smooth muscle cell apoptosis and improves survival in rats with pulmonary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

ErbB receptors: from oncogenes to targeted cancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Mechanisms of drug inhibition of signalling molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

The epidermal growth factor receptor family: biology driving targeted therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Disrupted pulmonary vascular development and pulmonary hypertension in transgenic mice overexpressing transforming growth factor-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

FDA drug approval summary: erlotinib (Tarceva) tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

FDA drug approval summary: lapatinib in combination with capecitabine for previously treated metastatic breast cancer that overexpresses HER-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Phosphodiesterase 1 upregulation in pulmonary arterial hypertension: target for reverse-remodeling therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Epidermal growth factor receptor (EGFR) signaling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Platelet-activating factor induces ovine fetal pulmonary venous smooth muscle cell proliferation: role of epidermal growth factor receptor transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Blockade of the epidermal growth factor receptor decreases intimal hyperplasia in balloon-injured rat carotid artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Epidermal growth factor regulates the expression of its own receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Arterial epidermal growth factor receptor expression in deoxycorticosterone acetate-salt hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Cross-talk between G protein-coupled receptor and epidermal growth factor receptor signaling pathways contributes to growth and invasion of head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Ligand-independent trans-activation of the platelet-derived growth factor receptor by reactive oxygen species requires protein kinase C-delta and c-Src

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

17beta-estradiol promotes breast cancer cell proliferation-inducing stromal cell-derived factor-1-mediated epidermal growth factor receptor transactivation: reversal by gefitinib pretreatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Activity of lapatinib is independent of EGFR expression level in HER2-overexpressing breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Lapatinib: current status and future directions in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Inhibition of EGFR signaling abrogates smooth muscle proliferation resulting from sustained distension of the urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Hypoxia and chronic lung disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp: a randomized, double-blind, placebo-controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC

Imatinib Mesylate in the Treatment of Refractory Idiopathic Pulmonary Arterial Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200811-1682OC